Explore the latest clinical guidelines, including US Preventive Services Task Force recommendations and synopses of specialty society guidelines.
This 2023 Recommendation Statement from the US Preventive Services Task Force recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy (B recommendation).
This systematic review to support the 2023 US Preventive Services Task Force Recommendation Statement on screening for hypertensive disorders of pregnancy summarizes published evidence on the benefits and harms of screening for hypertensive disorders of pregnancy using in-person and home-based blood pressure measurement.
This JAMA Patient Page describes the pros and cons of screening for high blood pressure disorders during pregnancy, and who should be screened.
This cross-sectional study of opioid prescription data compares changes in prescription rates by US state following the 2016 release of the US Centers for Disease Control and Prevention Guideline for Prescribing Opioids for Chronic Pain.
This cross-sectional study identifies and describes the integration of shared decision-making recommendations in contemporary cardiovascular clinical practice guidelines from 3 international societies.
This Viewpoint discusses ways in which future editions of DSM could address social determinants in the diagnosis and treatment of mental health disorders.
This viewpoint evaluates the CDC’s 2022 clinical practice guideline for prescribing opioids and suggests a model for supplemented shared decision-making between patients and clinicians about long-term opioid therapy.
This narrative review describes the types of endoleaks, their relative incidence, and their recommended management after endovascular aneurysm repair, including guidelines from US and European vascular surgical societies.
In this JAMA Patient Page, the US Preventive Services Task Force provides a guide to determine patient risk for HIV, who should take PrEP, and which PrEP strategies are recommended.
This 2023 Recommendation Statement from the US Preventive Services Task Force recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons at increased risk of HIV acquisition to decrease the risk of acquiring HIV (A recommendation).
This systematic review to support the 2023 US Preventive Services Task Force Recommendation Statement on preexposure prophylaxis (PrEP) for prevention of HIV infection summarizes published evidence on the benefits and harms of PrEP, including newer regimens, for persons at increased risk of HIV acquisition.
This consensus statement describes the process of creating evidence-based guidelines for postdural puncture headache that considered risk factors, preventive measures, and therapies and their adverse effects.
This JAMA Clinical Guidelines Synopsis summarizes the 2022 American Urological Association/Sexual Medicine Society of North America guidelines on diagnosis and management of priapism.
Customize your JAMA Network experience by selecting one or more topics from the list below.